Replies to post #516276 on NorthWest Biotherapeutics Inc (NWBO)

[jammy32]

Well that a big number to get to. I think investors would be happy with 2 dollars at this point. Anyways , hope you’re right with this one. I’m not seeing it on this one either. Sorry

[exwannabe]

No hope, just math...

So using Keytruda revenue, the most successful drug in history, is not "hope"?

As far as the math, I will gladly call BS on it. According to you, Keytruda is worth substantially more than MRK. That is absurd. Further, you keep talking about using Keytruda;s revenue numbers. Revenue is not earnings.

a DCF does not care about the number of shares or the market cap. That is why it is not the most definitive means of valuation. Someone should ask someone about the E/V analysis done and the numbers. That was the better analysis, more complete.

Either analysis can be presented per share or total value. It changes nothing.